Literature DB >> 363941

Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease.

S Izui, P J McConahey, F J Dixon.   

Abstract

Early in life, mice of four kinds [NZB, (NZB X NZW)F1, MRL/1, and male BXSB] with autoimmune disease spontaneously produced far more (greater than 3 S.D.) anti-hapten antibody-forming cells in spleens and greater concentrations of anti-hapten antibodies in sera than immunologically normal strains of mice (AKR, BALB/c, C57BL/6, DBA/1-J, DBA/2J, LG/J, 129, NZW, and female BXSB). This increased nonspecific antibody production by the abnormal animals' B cells correlated well with the spontaneous development of anti-single-stranded DNA antibodies, but not with serum levels of the viral envelope glycoprotein, gp70. These results suggest that the spontaneous formation of autoantibodies in mice whose immunologic disorder is manifested by a lupus-like disease may result from polyclonal activation of B cells by endogenous or exogenous B cell activators.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 363941

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  94 in total

1.  Abnormalities in clonable B lymphocytes and myeloid progenitors in autoimmune NZB mice.

Authors:  P W Kincade; G Lee; G Fernandes; M A Moore; N Williams; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Analysis of B-cell abnormalities in autoimmune mice by in vitro culture system using two types of bone marrow stromal cell clone.

Authors:  J Ohmori; T Ezaki; M Kotani
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

3.  Quantification of cross-reactive idiotype-positive rheumatoid factor produced in autoimmune rheumatic diseases. An indicator of clonality and B cell proliferative mechanisms.

Authors:  F Shokri; R A Mageed; G D Kitas; P Katsikis; H M Moutsopoulos; R Jefferis
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

4.  Immunologic abnormality in NZB/W F1 mice. Thymus-independent expansion of B cells responding to interleukin-6.

Authors:  M Mihara; H Fukui; Y Koishihara; M Saito; Y Ohsugi
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

5.  Qualitative difference of anti-DNA antibody-producing cell precursors in the pre-immune B cell repertoire between normal and lupus-prone mice.

Authors:  K Iwai; T Tsubata; Y Katsura; S Kumagai; H Imura
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

6.  Hidden autoantibodies against common serum proteins in murine systemic lupus erythematosus. Detection by in vitro plaque-forming cell assay.

Authors:  P L Cohen; R G Rapoport; R A Eisenberg
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

7.  Studies on the mechanism of peptidoglycan- and lipopolysaccharide-induced polyclonal activation.

Authors:  R Dziarski
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

8.  Single stranded DNA binding antibodies in patients with obstructive jaundice.

Authors:  G Ohshio; F Furukawa; T Manabe; T Tobe; Y Hamashima
Journal:  Jpn J Surg       Date:  1985-03

9.  Glomerular lesions induced in the rabbit by physicochemically altered homologous IgG.

Authors:  F Cavalot; M Miyata; A Vladutiu; V Terranova; S Dubiski; R Burlingame; E Tan; J Brentjens; F Milgrom; G Andres
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

10.  Injection of mouse thyroglobulin and/or adult thymectomy do not break tolerance to thyroglobulin during the lupus like graft versus host disease in mice.

Authors:  F M van Rappard-van der Veen; Y M Kong; N R Rose; M Kimura; E Gleichmann
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.